We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.85%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$1.71M
Cap. Flow
-$65.7M
Cap. Flow %
-3.73%
Top 10 Hldgs %
24.81%
Holding
276
New
14
Increased
59
Reduced
180
Closed
14

Top Buys

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$15M
2
EB
Eventbrite
EB
+$9.72M
3
ESTA icon
Establishment Labs
ESTA
+$9.35M
4
PRO
PROS Holdings
PRO
+$7.11M
5
PCRX icon
Pacira BioSciences
PCRX
+$6.75M

Top Sells

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$13.7M
2
MED icon
Medifast
MED
+$11.8M
3
PINC
Premier
PINC
+$11M
4
RVNC
Revance Therapeutics, Inc.
RVNC
+$8M
5
MEDP icon
Medpace
MEDP
+$7.15M

Sector Composition

Rank Sector Weight
1 Healthcare 28.23%
2 Technology 24.76%
3 Industrials 19.11%
4 Consumer Discretionary 9.18%
5 Communication Services 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCPH
226
DELISTED
scPharmaceuticals
SCPH
$813K 0.05%
+79,830
New +$833K
DLB icon
227
Dolby
DLB
$5.79B
$794K 0.05%
9,493
-10,000
-51% -$836K
DVN icon
228
Devon Energy
DVN
$47.3B
$793K 0.05%
16,402
-8,538
-34% -$429K
KEX icon
229
Kirby Corp
KEX
$6.93B
$790K 0.04%
10,268
-10,035
-49% -$722K
URGN icon
230
UroGen Pharma
URGN
$2.29B
$788K 0.04%
76,087
+2,882
+4% +$31.8K
IEX icon
231
IDEX
IEX
$17.3B
$763K 0.04%
3,546
-3,364
-49% -$707K
NOTV
232
DELISTED
Inotiv
NOTV
$739K 0.04%
154,979
+6,525
+4% +$36K
EXEL icon
233
Exelixis
EXEL
$13.4B
$736K 0.04%
38,519
-41,183
-52% -$794K
CIEN icon
234
Ciena
CIEN
$58.4B
$697K 0.04%
16,397
-15,045
-48% -$685K
ABBV icon
235
AbbVie
ABBV
$435B
$658K 0.04%
4,886
-75
-2% -$11K
YMAB
236
DELISTED
Y-mAbs Therapeutics
YMAB
$632K 0.04%
93,022
+3,542
+4% +$26.5K
TDY icon
237
Teledyne Technologies
TDY
$32B
$597K 0.03%
1,453
-886
-38% -$365K
CVX icon
238
Chevron
CVX
$366B
$588K 0.03%
3,737
– –
CDW icon
239
CDW
CDW
$17B
$582K 0.03%
3,173
-3,562
-53% -$622K
ABT icon
240
Abbott
ABT
$187B
$576K 0.03%
5,286
-100
-2% -$10.7K
CXT icon
241
Crane NXT
CXT
$3.07B
$549K 0.03%
9,727
-41,349
-81% -$2.1M
AAPL icon
242
Apple
AAPL
$4.57T
$543K 0.03%
2,800
– –
MP icon
243
MP Materials
MP
$9.1B
$523K 0.03%
22,858
-22,074
-49% -$506K
GBCI icon
244
Glacier Bancorp
GBCI
$6.35B
$520K 0.03%
16,671
-10,000
-37% -$330K
BRK.A icon
245
Berkshire Hathaway Class A
BRK.A
$1.12T
$518K 0.03%
1
– –
J icon
246
Jacobs Solutions
J
$17B
$421K 0.02%
4,286
– –
SYY icon
247
Sysco
SYY
$40.3B
$412K 0.02%
5,552
-150
-3% -$11.1K
XOM icon
248
ExxonMobil
XOM
$634B
$391K 0.02%
3,650
-93
-2% -$10.1K
SRRK icon
249
Scholar Rock
SRRK
$6.44B
$361K 0.02%
47,822
+1,601
+3% +$12.1K
MCO icon
250
Moody's
MCO
$82.7B
$323K 0.02%
928
-43
-4% -$13.6K
8 9
10
11 12

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Rice Hall James & Associates held 276 positions worth $1.76B, up 0.1% from $1.76B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $65.7M in Q2 2023, closing 14 positions and reducing 180 holdings. Its most notable exit was Semtech, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in BioCryst Pharmaceuticals worth $13.2M.

  • Rice Hall James & Associates's largest Q2 2023 buy was BioCryst Pharmaceuticals: 1,872,964 shares worth $13.2M.
  • Rice Hall James & Associates added most to Eventbrite in Q2 2023, an estimated $9.72M increase.
  • Rice Hall James & Associates's biggest Q2 2023 reduction was Premier, cutting an estimated $11M.
  • Rice Hall James & Associates fully exited Semtech in Q2 2023, selling an estimated $13.7M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.76B portfolio in Q2 2023.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q2 2023.
  • Rice Hall James & Associates's portfolio value rose 0.1% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.